“HSBC sets a target price of ₹1,200 for Fortis Healthcare, implying a 30% upside, as the hospital chain enters a new growth phase. Strong earnings visibility is expected, driven by an improving case mix, rising profitability at hospitals with lower EBITDA margins, and calibrated capacity expansion.”